<p>Data correspond to those illustrated in <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0080128#pone-0080128-g004" target="_blank">figure 4C</a>. Time to onset was compared using Wilcoxon's survival test; MMSs were compared using Wilcoxon's non-parametric test; Change in body weight at the end of the study was compared using Student's t-test.</p><p><sup>*</sup> Statistically significant value.</p
<p>(A) EAE disease incidence in wild-type (WT; <i>n</i> = 17) and Olig1<sup>−/−</sup> (<i>n</i> = 20...
<p>Male C57BL/6 mice were immunized with MOG-35-55/CFA/Ptx. Mice were scored for clinical signs of E...
<p>Incidence in at-EAE mice (A) and active EAE mice (B) between day 7 and 15 after immunization or a...
<p>Data correspond to those illustrated in <a href="http://www.plosone.org/article/info:doi/10.1371/...
<p>(A): Wild-type (WT, n = 16) and t-PA<sup>-/-</sup> mice (n = 9) were immunized with the MOG<sub>3...
<p>EAE was induced actively with MOG<sub>35–55</sub> in complete Freund's adjuvant in MK2<sup>−/−</s...
<p>Data are shown as mean ± SEM. <sup>a)</sup>Mice reached a peak of disease severity at day 22 afte...
<p><b>(A)</b> Mean clinical score of four independent experiments testing the preventive potential o...
<p>(<b>A - right</b>) Time course of clinical signs recorded from Panx1 wild type (WT) and Panx1 kno...
<p>EAE was induced by immunonization with MOG (<a href="http://www.plosone.org/article/info:doi/10.1...
<p>EAE was assessed fourteen days after C57BL/6 mice were immunized with MOG peptide<sub>35<b>–</b>5...
<p>C57BL/6 mice were biolistically transfected with the indicated plasmid combinations in equimolar ...
<p>Mice were infected with γHV-68 (dashed line) or LCMV or MEM only (solid lines). Five weeks p.i. E...
<p>Paralysis in EAE-affected mice was assessed by clinical scoring up to 23 days post-immunisation. ...
<p>Mice were injected i.v. (days −7, −5, −3) with PBS, WT DC or B7-H1<sup>−/−</sup> DC and on day 0 ...
<p>(A) EAE disease incidence in wild-type (WT; <i>n</i> = 17) and Olig1<sup>−/−</sup> (<i>n</i> = 20...
<p>Male C57BL/6 mice were immunized with MOG-35-55/CFA/Ptx. Mice were scored for clinical signs of E...
<p>Incidence in at-EAE mice (A) and active EAE mice (B) between day 7 and 15 after immunization or a...
<p>Data correspond to those illustrated in <a href="http://www.plosone.org/article/info:doi/10.1371/...
<p>(A): Wild-type (WT, n = 16) and t-PA<sup>-/-</sup> mice (n = 9) were immunized with the MOG<sub>3...
<p>EAE was induced actively with MOG<sub>35–55</sub> in complete Freund's adjuvant in MK2<sup>−/−</s...
<p>Data are shown as mean ± SEM. <sup>a)</sup>Mice reached a peak of disease severity at day 22 afte...
<p><b>(A)</b> Mean clinical score of four independent experiments testing the preventive potential o...
<p>(<b>A - right</b>) Time course of clinical signs recorded from Panx1 wild type (WT) and Panx1 kno...
<p>EAE was induced by immunonization with MOG (<a href="http://www.plosone.org/article/info:doi/10.1...
<p>EAE was assessed fourteen days after C57BL/6 mice were immunized with MOG peptide<sub>35<b>–</b>5...
<p>C57BL/6 mice were biolistically transfected with the indicated plasmid combinations in equimolar ...
<p>Mice were infected with γHV-68 (dashed line) or LCMV or MEM only (solid lines). Five weeks p.i. E...
<p>Paralysis in EAE-affected mice was assessed by clinical scoring up to 23 days post-immunisation. ...
<p>Mice were injected i.v. (days −7, −5, −3) with PBS, WT DC or B7-H1<sup>−/−</sup> DC and on day 0 ...
<p>(A) EAE disease incidence in wild-type (WT; <i>n</i> = 17) and Olig1<sup>−/−</sup> (<i>n</i> = 20...
<p>Male C57BL/6 mice were immunized with MOG-35-55/CFA/Ptx. Mice were scored for clinical signs of E...
<p>Incidence in at-EAE mice (A) and active EAE mice (B) between day 7 and 15 after immunization or a...